Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 22% ± 5% | |
| astrocyte | 4 studies | 26% ± 5% | |
| glutamatergic neuron | 4 studies | 29% ± 10% | |
| oligodendrocyte precursor cell | 4 studies | 19% ± 3% | |
| oligodendrocyte | 4 studies | 19% ± 2% | |
| ciliated cell | 3 studies | 20% ± 2% | |
| GABAergic neuron | 3 studies | 27% ± 5% | |
| macrophage | 3 studies | 21% ± 1% | |
| endothelial cell | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1418.96 | 1445 / 1445 | 100% | 21.71 | 183 / 183 |
| lung | 100% | 1232.52 | 578 / 578 | 100% | 16.96 | 1155 / 1155 |
| prostate | 100% | 1252.44 | 245 / 245 | 100% | 16.10 | 501 / 502 |
| ovary | 100% | 1008.41 | 180 / 180 | 100% | 11.70 | 429 / 430 |
| breast | 100% | 1497.98 | 459 / 459 | 100% | 27.90 | 1115 / 1118 |
| brain | 100% | 922.82 | 2637 / 2642 | 100% | 20.02 | 704 / 705 |
| stomach | 100% | 1025.27 | 359 / 359 | 100% | 17.95 | 285 / 286 |
| bladder | 100% | 1492.62 | 21 / 21 | 99% | 13.52 | 499 / 504 |
| uterus | 100% | 1305.12 | 170 / 170 | 99% | 12.13 | 454 / 459 |
| thymus | 100% | 1193.51 | 653 / 653 | 99% | 12.02 | 598 / 605 |
| intestine | 100% | 1474.12 | 966 / 966 | 99% | 16.46 | 520 / 527 |
| kidney | 100% | 1085.28 | 89 / 89 | 98% | 14.28 | 883 / 901 |
| pancreas | 98% | 577.18 | 322 / 328 | 99% | 13.89 | 176 / 178 |
| skin | 100% | 1853.98 | 1809 / 1809 | 94% | 12.97 | 443 / 472 |
| liver | 100% | 593.66 | 226 / 226 | 94% | 8.32 | 381 / 406 |
| adrenal gland | 100% | 1306.13 | 258 / 258 | 92% | 9.07 | 211 / 230 |
| adipose | 100% | 1532.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1419.26 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1223.35 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 892.11 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.19 | 1 / 1 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 13.34 | 44 / 45 |
| heart | 97% | 869.48 | 838 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 8.27 | 27 / 29 |
| peripheral blood | 78% | 667.54 | 722 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 69% | 5.74 | 55 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0015031 | Biological process | protein transport |
| GO_0036211 | Biological process | protein modification process |
| GO_0008333 | Biological process | endosome to lysosome transport |
| GO_0008150 | Biological process | biological_process |
| GO_0019752 | Biological process | carboxylic acid metabolic process |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0000813 | Cellular component | ESCRT I complex |
| GO_0016616 | Molecular function | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO_0043130 | Molecular function | ubiquitin binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | UEVLD |
| Protein name | Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) UEV and lactate/malate dehyrogenase domains |
| Synonyms | UEV3 |
| Description | FUNCTION: Possible negative regulator of polyubiquitination. . |
| Accessions | ENST00000535484.5 [Q8IX04-4] ENST00000541984.5 [Q8IX04-7] ENST00000300038.7 [Q8IX04-5] ENST00000320750.10 [Q8IX04-3] ENST00000543987.5 [Q8IX04-2] Q8IX04 A8MYV4 ENST00000396196.6 ENST00000379387.8 [Q8IX04-6] ENST00000396197.8 [Q8IX04-1] |
